RecruitingNot applicableNCT07563322

Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension

Studying Pulmonary arterial hypertension

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vanderbilt University Medical Center
Principal Investigator
Evan L Brittain, MD
VUMC
Intervention
Nicotinamide Riboside (NR)(dietary_supplement)
Enrollment
10 enrolled
Eligibility
18-85 years · All sexes
Timeline
20262027

Study locations (1)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07563322 on ClinicalTrials.gov

Other trials for Pulmonary arterial hypertension

Additional recruiting or active studies for the same condition.

See all trials for Pulmonary arterial hypertension

← Back to all trials